NEWS & VIEWS

Global private equity and venture capital news and research

Posts Tagged ‘Lundbeckfond Ventures’

28 March 2014

Biopharma developer scPharmaceuticals seals $16m Series A VC round

Biopharmaceutical company scPharmaceuticals has closed a $16m Series A venture financing round co-led by life sciences investors 5AM Ventures and Lundbeckfond Ventures.

25 February 2014

Novo Ventures leads $49m Series B for anti-acne business Thesan Pharmaceuticals

skin5_lrg Biotechnology business Thesan Pharmaceuticals, which aims to treat skin disorders including acne and dermatitis, has picked up $49m of Series B financing led by existing backer Novo Ventures.

1 October 2013

Bay City Capital, Lundbeckfond latest venture investors in drug accelerator Cydan

drug pharma bottle Bay City Capital and Lundbeckfond Ventures have brought drug accelerator Cydan’s total funding to $26m by backing a new financing round.

15 April 2013

Lundbeckfond Ventures backs DySIS Medical with £6m

Edinburgh-based medical devices maker DySIS Medical has raised £7.4m from venture capital firm Lundbeckfond Ventures and its existing investors.


Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2014